Title Human H 7 N 9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H 7 N 9 virus

Background: Avian influenza virus H7N9 has jumped species barrier, causing sporadic human infections since 2013. We have previously isolated an H7N9 virus from a patient, and an H7N9 virus from a chicken in a live poultry market where the patient visited during the incubation period. These two viruses were genetically highly similar. This study sought to use a human bronchial epithelial cell line model to infer the virulence of these H7N9 viruses in humans. Methods: Human bronchial epithelial cell line Calu-3 was infected with two H7N9 viruses (human H7N9-HU and chicken H7N9-CK), a human H5N1 virus and a human 2009 pandemic H1N1 virus. The infected cell lysate was collected at different time points post-infection for the determination of the levels of pro-inflammatory cytokines (tumor necrosis factor α [TNF-α] and interleukin 6 [IL-6]), anti-inflammatory cytokines (interleukin 10 [IL-10] and transforming growth factor beta [TGF-β]), chemokines (interleukin 8 [IL-8] and monocyte chemoattractant protein 1 [MCP-1]), and interferons (interferon β [IFN-β] and interferon lambda 1 [IFNL1]). The viral load in the cell lysate was also measured. Results: Comparison of the human and chicken H7N9 viruses showed that H7N9-HU induced significantly higher levels of TNF-α at 12 h post-infection, and significantly higher levels of IL-8 from 12 to 48 h post-infection than those of H7N9-CK. However, the level of IFNL1 was lower for H7N9-HU than that of H7N9-CK at 48 h post-infection (P < 0.001). H7N9-HU had significantly higher viral loads than H7N9-CK at 3 and 6 h post-infection. H5N1 induced significantly higher levels of TNF-α, IL-6, IL-8, IL-10 and MCP-1 than those of H7N9 viruses at 48 h post-infection. Conversely, H1N1 induced lower levels of TNF-α, IL-10, MCP-1, IFNL1 and IFN-β when compared with H7N9 viruses at the same time point. (Continued on next page) * Correspondence: kyyuen@hku.hk Equal contributors Department of Microbiology, The University of Hong Kong, Hong Kong Special Administrative Region, China State Key Laboratory for Emerging Infectious Diseases, The University of Hong Kong, Hong Kong Special Administrative Region, China Full list of author information is available at the end of the article © 2016 To et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. To et al. Virology Journal (2016) 13:42 DOI 10.1186/s12985-016-0498-2

[1]  K. Zen,et al.  Pro-inflammatory cytokine dysregulation is associated with novel avian influenza A (H7N9) virus in primary human macrophages. , 2016, The Journal of general virology.

[2]  K. To,et al.  Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes , 2015, Clinical and Vaccine Immunology.

[3]  Shigui Yang,et al.  The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes , 2015, Scientific Reports.

[4]  T. Tumpey,et al.  A(H7N9) Virus Results in Early Induction of Proinflammatory Cytokine Responses in both Human Lung Epithelial and Endothelial Cells and Shows Increased Human Adaptation Compared with Avian H5N1 Virus , 2015, Journal of Virology.

[5]  J. Shelhamer,et al.  Validation of Normal Human Bronchial Epithelial Cells as a Model for Influenza A Infections in Human Distal Trachea , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  Ha T. Nguyen,et al.  Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. , 2015, The Journal of infectious diseases.

[7]  Qun Li,et al.  Poultry farms as a source of avian influenza A (H7N9) virus reassortment and human infection , 2015, Scientific Reports.

[8]  T. Yeo,et al.  Avian Influenza (H7N9) Virus Infection in Chinese Tourist in Malaysia, 2014 , 2015, Emerging infectious diseases.

[9]  Qibin Zhang,et al.  A comprehensive collection of systems biology data characterizing the host response to viral infection , 2014, Scientific Data.

[10]  K. To,et al.  Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor , 2014, PloS one.

[11]  M. Katze,et al.  H7N9 and Other Pathogenic Avian Influenza Viruses Elicit a Three-Pronged Transcriptomic Signature That Is Reminiscent of 1918 Influenza Virus and Is Associated with Lethal Outcome in Mice , 2014, Journal of Virology.

[12]  J. Chan,et al.  Viral lung infections: Epidemiology, virology, clinical features, and management of avian influenza A(H7N9) , 2014, Current opinion in pulmonary medicine.

[13]  K. To,et al.  Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong , 2014, Journal of Infection.

[14]  M. Katze,et al.  Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options , 2014, mBio.

[15]  T. Allen,et al.  Interleukin 8 and acute lung injury. , 2014, Archives of pathology & laboratory medicine.

[16]  Q. Jin,et al.  Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013 , 2014, Emerging infectious diseases.

[17]  Ruifu Yang,et al.  Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus , 2014, Nature Communications.

[18]  K. To,et al.  Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. , 2014, The Journal of infectious diseases.

[19]  T. Kuiken,et al.  Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.

[20]  P. Doherty,et al.  Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection , 2013, Proceedings of the National Academy of Sciences.

[21]  Zheng Xing,et al.  Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. , 2013, The Journal of infectious diseases.

[22]  Kwok-Hung Chan,et al.  Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. , 2013, The Journal of general virology.

[23]  A. Gruber,et al.  The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue , 2013, mBio.

[24]  J. Chan,et al.  The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities , 2013, The Lancet Infectious Diseases.

[25]  K. To,et al.  Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Guohua Deng,et al.  H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet , 2013, Science.

[27]  Y. Guan,et al.  Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract , 2013, The Lancet Respiratory Medicine.

[28]  Noriko Kishida,et al.  Characterization of H7N9 influenza A viruses isolated from humans , 2013, Nature.

[29]  Huachen Zhu,et al.  Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice , 2013, mBio.

[30]  Jie Dong,et al.  Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .

[31]  Wenjun Song,et al.  Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.

[32]  K. To,et al.  Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. , 2013, The Journal of infectious diseases.

[33]  K. To,et al.  Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation , 2013, The Journal of infectious diseases.

[34]  Honglin Chen,et al.  Avian influenza A H5N1 virus: a continuous threat to humans , 2012, Emerging Microbes & Infections.

[35]  Herman Tse,et al.  Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? , 2012, Clinical Microbiology Reviews.

[36]  R. Sugrue,et al.  Activation of Type I and III Interferon Signalling Pathways Occurs in Lung Epithelial Cells Infected with Low Pathogenic Avian Influenza Viruses , 2012, PloS one.

[37]  N. Cox,et al.  Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets , 2012, Proceedings of the National Academy of Sciences.

[38]  Chengjun Li,et al.  Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems , 2011, BMC Systems Biology.

[39]  K. To,et al.  The Lower Serum Immunoglobulin G2 Level in Severe Cases than in Mild Cases of Pandemic H1N1 2009 Influenza Is Associated with Cytokine Dysregulation , 2010, Clinical and Vaccine Immunology.

[40]  V. Chow,et al.  MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. , 2010, American journal of respiratory cell and molecular biology.

[41]  Samson S. Y. Wong,et al.  Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  P. Woo,et al.  Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies , 2010, The Journal of infectious diseases.

[43]  J. Chan,et al.  Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[44]  K. Hartshorn,et al.  Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-λ1) in Response to Influenza A Infection1 , 2009, The Journal of Immunology.

[45]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.